David C. Sachs

IBRX

David C. Sachs serves as Chief Financial Officer at ImmunityBio, Inc. (IBRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$380.3K

Net Position

Net Seller

$380.3K

Companies Traded

IBRX

Active Period

Feb 2025 – Feb 2026

3 total trades

Most Recent

Sell IBRX

Feb 10, 2026 · $295.5K

David C. Sachs's Insider Trading at ImmunityBio, Inc. (IBRX)

Buys

0 · $0.00

Sells

3 · $380.3K

Total Shares Bought

Total Shares Sold

73,938

IBRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 10, 2026	Sell	42,643	$6.93	$295.5K
Dec 31, 2025	Sell	15,435	$1.98	$30.6K
Feb 22, 2025	Sell	15,860	$3.42	$54.2K

Related Insiders

Cheryl Cohen

director

IBRXSell · Oct 6, 2026

Barry J. Simon

Director

IBRXSell · Oct 6, 2026

Christobel Selecky

Director

IBRXSell · Jul 6, 2026

Richard Adcock

CEO & President

IBRXSell · Feb 10, 2026

LAUER REGAN J

Chief Accounting Officer

IBRXSell · Feb 10, 2026

SOON-SHIONG PATRICK

See remarks

IBRXSell · Feb 10, 2026

Explore More Insider Trading Data

IBRX Insider Trading Activity

View all insider trades at ImmunityBio, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity